摘要
本文系统分析了人类细小病毒B19的特征及其对血液制品安全性的影响,以及国外对B19的风险控制策略。为建立我国相关技术要求和指南,保障血液/血液制品的病毒安全提供一定的参考。
Characterization of human parvovirus B19 and its effects on the safety of blood/blood products were systemically analyzed,and foreign safety control strategies of human parvovirus B19 were described.It provides a valuable reference for the establishment of relevant standards and guidelines in China,which ensures the viral safety of blood/blood products.
作者
刘彬
魏琼书
马莉
李长清
LIU Bin;WEI Qiongshu;MA Li;LI Changqing(Institute of Blood Transfusion,Chinese Academy of Medical Sciences&Peking Union Medical College,Chengdu 610052,China)
出处
《中国药品标准》
CAS
2022年第2期152-155,共4页
Drug Standards of China
基金
国家药典委员会药品标准制修订研究课题资助项目(2019S01,2020S04)。
